Détention brevets de la classe C40B 40/02

Brevets de cette classe: 609

Historique des publications depuis 10 ans

25
25
54
52
38
28
23
37
23
7
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc.
282
38
The Regents of the University of California
20355
20
Massachusetts Institute of Technology
10181
8
President and Fellows of Harvard College
6049
8
Yale University
2461
8
Genentech, Inc.
4040
7
Adimab, LLC
149
7
The Governing Council of The University of Toronto,
1522
7
DuPont US Holding, LLC
93
7
48Hour Discovery Inc.
10
7
Affinity Biosciences Pty Ltd
10
6
National Research Council of Canada
1579
6
The University of British Columbia
1536
6
The Board of Trustees of the Leland Stanford Junior University
6594
5
Adaptimmune Limited
165
5
CytomX Therapeutics, Inc.
231
5
The Governors of the University of Alberta
874
5
Immunocore Limited
225
5
Nantbio, Inc.
141
5
Centre National de La Recherche Scientifique
10801
4
Autres propriétaires 440